Fatty liver disease, the new crisis of white-collar workers
With economic development, improvement of living standards, the incidence of fatty liver disease on the rise and the trend of younger, it has become a “white-collar workers,” the health of new crises. And, more frightening is that, once suffering from fatty liver disease is likely to spread to the body, gave rise to unimaginable catastrophe. Therefore, for prevention and treatment of fatty liver disease is not only a medical problem, but also a social problem.
Disease for different reasons in different regions
At different times, different countries and populations, the composition ratio of the cause of fatty liver disease, clinical manifestations and prognosis of mixed. For example, in the “three difficult years”, China’s rural population is especially prevalent malnutrition, fatty liver disease.
But in recent years, as the economy raises the level of lipids increased food and drinking, obesity, diabetes, hyperlipidemia, Shanghai and other developed areas has become a major cause of fatty liver disease, while the north and the ethnic minority areas fatty liver disease is mainly caused by alcoholism. However, sometimes there are several causes of a patient exist, such as alcohol consumption, hepatitis virus infection, obesity and drug and other factors co-exist.
Judging from the current situation, fatty liver disease the most common for two reasons, first because of insulin resistance as the central link due to the non-alcoholic fatty liver disease; second is caused by excessive drinking of alcoholic fatty liver disease. Among them, the former incidence rate is 7-10 times the incidence of the latter.
Non-alcoholic fatty liver disease is more need to be alert
Alcoholic liver disease is due to drinking large quantities of lead poisoning-induced liver injury, its performance has varied, the initial fatty liver disease usually presents in turn can develop into alcohol-induced hepatitis, alcoholic hepatic fibrosis and alcoholic liver cirrhosis.
However, the real result of the liver due to alcohol being such a disaster after all, a minority, but as long as early as day away from the alcohol, would not fall into the quagmire of liver disease. Therefore, from this sense, non-alcoholic fatty liver disease is more need to be vigilant.
Non-alcoholic fatty liver disease and metabolic abnormalities mainly related diseases, such as: rapid weight gain, visceral obesity, diabetes, high blood lipids, high blood pressure and other factors. Now, with the incidence of obesity and diabetes increase, non-alcoholic fatty liver disease that seriously endangers the health of the global population. In developed countries, such liver disease have been about 20% of the total population; in my country, it has become our country, one of the most common chronic liver disease. Develop a healthy lifestyle is the best thing to be done, such as drink less, eat low-fat, low-carbohydrate diet, do aerobic exercise.
A timely manner in order to avoid the tragedy of drug use
It is worth recalling that, due to alcoholic liver disease in severe alcoholism may induce a wide range of liver cell necrosis or even liver failure; non-alcoholic fatty liver disease if not treated in time, will be developed into a simple fatty liver disease, as well as by the evolution of steatohepatitis and cirrhosis. Therefore, lifestyle intervention alone is clearly not enough. If you can not timely medication of the drug is likely to last a rude awakening. Because, at present no clinical cure can not hepatitis, cirrhosis and liver cancer effective drugs. The most positive and effective measures are: the initiative to prevent fatty liver disease, active treatment fatty liver disease, from the source to prevent the occurrence of a variety of end-stage liver disease.
Natural plant chemical drugs, silibinin capsules (water Chia), being able to fully protect the liver cells, the liver weight by more and more popular. Medical and health science and technology by the Ministry of Health chaired the Development Research Center, Beijing Ditan Hospital, commitment, and nearly one hundred hospitals nationwide to participate, Tianjin Tasly Pharmaceutical Marketing Group Co., Ltd. supports the “status of fatty liver disease epidemiology and clinical intervention study “is also in progress, I believe that will give patients more bring the Gospel!